376 Radiation sub-study to characterize safety and tolerability of low-dose radiation in combination with afami-cel in patients with advanced cancers (NCT03132922)

• Ruoxi Wang,
• David Hong,
• James Welsh,
• Stavros Rafail,
• Hampartsoum Barsoumian,
• Jean-Marc Navenot,
• Jane Bai,
• Amy Sauer,
• Quan Lin,
• Danxia Ke,
• Nahum Puebla Osorio,
• Bryan Jackson,
• Marisa Rosenberg,
• Cheryl McAlpine,
• Robyn Broad,
• Ashley Liddle,
• Hassan Danesi

Affiliations

Ruoxi Wang

School of Public Health and Management, Chongqing Medical University, Chongqing, China

David Hong

1MD Anderson Cancer Center, Houston, TX, USA

James Welsh

1MD Anderson Cancer Center, Houston, TX, USA

Stavros Rafail

Aff432 grid.25879.310000000419368972University of Pennsylvania Philadelphia PA USA

Hampartsoum Barsoumian

1MD Anderson Cancer Center, Houston, TX, USA

Jean-Marc Navenot

6Adaptimmune, Philadelphia, PA, USA

Jane Bai

6Adaptimmune, Philadelphia, PA, USA

Amy Sauer

6Adaptimmune, Philadelphia, PA, USA

Quan Lin

5Adaptimmune, Philadelphia, PA, USA

Danxia Ke

2 Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Nahum Puebla Osorio

1The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Bryan Jackson

2Adaptimmune, Philadelphia, PA, USA

Marisa Rosenberg

2Adaptimmune, Philadelphia, PA, USA

Cheryl McAlpine

2Adaptimmune, Philadelphia, PA, USA

Robyn Broad

2Adaptimmune, Philadelphia, PA, USA

Ashley Liddle

2Adaptimmune, Philadelphia, PA, USA

Hassan Danesi

2Adaptimmune, Philadelphia, PA, USA